These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19183457)

  • 1. Heat-shock proteins in infection-mediated inflammation-induced tumorigenesis.
    Goldstein MG; Li Z
    J Hematol Oncol; 2009 Jan; 2():5. PubMed ID: 19183457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, inflammation, and cancer: how are they linked?
    Reuter S; Gupta SC; Chaturvedi MM; Aggarwal BB
    Free Radic Biol Med; 2010 Dec; 49(11):1603-16. PubMed ID: 20840865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
    Lu B; Yang M; Wang Q
    J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond.
    Lang BJ; Guerrero-Giménez ME; Prince TL; Ackerman A; Bonorino C; Calderwood SK
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying chronic inflammation-associated cancers.
    Wu Y; Antony S; Meitzler JL; Doroshow JH
    Cancer Lett; 2014 Apr; 345(2):164-73. PubMed ID: 23988267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.
    Elinav E; Nowarski R; Thaiss CA; Hu B; Jin C; Flavell RA
    Nat Rev Cancer; 2013 Nov; 13(11):759-71. PubMed ID: 24154716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.
    Valencia T; Kim JY; Abu-Baker S; Moscat-Pardos J; Ahn CS; Reina-Campos M; Duran A; Castilla EA; Metallo CM; Diaz-Meco MT; Moscat J
    Cancer Cell; 2014 Jul; 26(1):121-135. PubMed ID: 25002027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis.
    Brigelius-Flohé R; Kipp AP
    Ann N Y Acad Sci; 2012 Jul; 1259():19-25. PubMed ID: 22758632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and cancer: the oncogene-driven connection.
    Borrello MG; Degl'Innocenti D; Pierotti MA
    Cancer Lett; 2008 Aug; 267(2):262-70. PubMed ID: 18502035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis.
    Balahura LR; Selaru A; Dinescu S; Costache M
    J Immunol Res; 2020; 2020():2549763. PubMed ID: 33015196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the mediators of inflammation in cancer development.
    Fernandes JV; Cobucci RN; Jatobá CA; Fernandes TA; de Azevedo JW; de Araújo JM
    Pathol Oncol Res; 2015 Jul; 21(3):527-34. PubMed ID: 25740073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
    Njunge LW; Estania AP; Guo Y; Liu W; Yang L
    Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins in physiology and pathology: the Berlin meeting.
    Asea AA; Milani V; Calderwood SK
    Cell Stress Chaperones; 2007; 12(3):205-8. PubMed ID: 17915552
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisiting the canonical tumour progression model.
    Ansieau S; Hinkal G; Morel AP; Puisieux A
    Pathol Biol (Paris); 2011 Dec; 59(6):294-7. PubMed ID: 20227838
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic inflammation and cancer: the role of the mitochondria.
    Kamp DW; Shacter E; Weitzman SA
    Oncology (Williston Park); 2011 Apr; 25(5):400-10, 413. PubMed ID: 21710835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aneuploidy as a promoter and suppressor of malignant growth.
    Vasudevan A; Schukken KM; Sausville EL; Girish V; Adebambo OA; Sheltzer JM
    Nat Rev Cancer; 2021 Feb; 21(2):89-103. PubMed ID: 33432169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.
    Baglole CJ; Ray DM; Bernstein SH; Feldon SE; Smith TJ; Sime PJ; Phipps RP
    Immunol Invest; 2006; 35(3-4):297-325. PubMed ID: 16916756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.
    Manjili MH
    Cancer Res; 2017 May; 77(10):2564-2569. PubMed ID: 28507050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.
    Chatterjee S; Burns TF
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.